vTv Therapeutics inks licensing agreement for diabetes therapies

Vtv Therapeutics Inc. has entered into a licensing agreement with a Chinese pharmaceutical company for one of its diabetes therapies to be developed and commercialized in China and other Pacific Rim countries.   The agreement with Hangzhou Zhongmei Huadong Pharmaceutical Co. Ltd. gives the company an exclusive license to develop, manufacture and commercialize vTv Therapeutics’ therapy in places, such as China, Hong Kong, Thailand, Cambodia, South Korea and Australia.  VTv Therapeutics (Nasdaq:…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news